Literature DB >> 21224060

CC chemokine receptor 4 contributes to innate NK and chronic stage T helper cell recall responses during Mycobacterium bovis infection.

Valerie R Stolberg1, Bo-Chin Chiu, Brian M Schmidt, Steven L Kunkel, Matyas Sandor, Stephen W Chensue.   

Abstract

Cysteine-cysteinyl chemokine receptor 4 (CCR4) is expressed by a variety of T-cell subsets and leukocytes. This study examined the participation of CCR4 in response to pulmonary infection with Mycobacterium bovis Bacille-Calmette-Guerin (BCG). Constitutive and induced CCR4 agonist expression was detected among large mononuclear cells. The course of infection and mobilization of effector cell populations were then analyzed in CCR4 knockout (CCR4(-/-)) mice. Compared with controls, CCR4(-/-) mice displayed delayed innate stage (<2 weeks) bacterial clearance and reduced late stage inflammation. Innate impairment was associated with reduced natural killer cell activation. In the adaptive phase, CCR4(-/-) mice generated effector T cells in draining lymph nodes and accumulated effector T cells in lungs, which resulted in normal adaptive stage bacterial elimination at 2 to 4 weeks. However, during the late stage, CCR4(-/-) mice had reduced interferonγ+CD4(+)α/β+ (Th1) and interleukin (IL)-17+CD4(+)α/β+ (Th17) T helper cells in lungs. In contrast, IL-17+ γ/δ T cells in lungs were unaffected. When challenged with mycobacterial antigen- (Ag-) Ag-coated beads to elicit a recall granulomatous response, CCR4(-/-) mice displayed abrogated recall granuloma formation and reduced interferon γ+ Th1 cells. These findings indicate that CCR4 supports innate natural killer cell activation and sustains later CD4(+) Th effector/memory antimycobacterial responses in the lung but is redundant in the early adaptive elimination phase. Copyright Â
© 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21224060      PMCID: PMC3069872          DOI: 10.1016/j.ajpath.2010.11.036

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

Review 1.  Innate immunity in tuberculosis: myths and truth.

Authors:  Daniel S Korbel; Bianca E Schneider; Ulrich E Schaible
Journal:  Microbes Infect       Date:  2008-08-13       Impact factor: 2.700

Review 2.  The plasticity of gamma delta T cells: innate immunity, antigen presentation and new immunotherapy.

Authors:  Rita Casetti; Angelo Martino
Journal:  Cell Mol Immunol       Date:  2008-06       Impact factor: 11.530

3.  A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.

Authors:  C Vestergaard; K Bang; B Gesser; H Yoneyama; K Matsushima; C G Larsen
Journal:  J Invest Dermatol       Date:  2000-10       Impact factor: 8.551

4.  Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309.

Authors:  M Inngjerdingen; B Damaj; A A Maghazachi
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

5.  The same well-characterized T cell epitope SIINFEKL expressed in the context of a cytoplasmic or secreted protein in BCG induces different CD8+ T cell responses.

Authors:  Paul D Hulseberg; Alla Zozulya; Hamlet H Chu; James A Triccas; Zsuzsanna Fabry; Matyas Sandor
Journal:  Immunol Lett       Date:  2009-12-11       Impact factor: 3.685

6.  Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses.

Authors:  Liyou Qiu; Dan Huang; Cystal Y Chen; Richard Wang; Ling Shen; Yun Shen; Robert Hunt; James Estep; Barton F Haynes; William R Jacobs; Norman Letvin; George Du; Zheng W Chen
Journal:  J Infect Dis       Date:  2008-11-15       Impact factor: 5.226

7.  Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans.

Authors:  Daniela Fenoglio; Alessandro Poggi; Silvia Catellani; Florinda Battaglia; Alessandra Ferrera; Maurizio Setti; Giuseppe Murdaca; Maria Raffaella Zocchi
Journal:  Blood       Date:  2009-04-24       Impact factor: 22.113

Review 8.  IL-23 and IL-17 in tuberculosis.

Authors:  Shabaana A Khader; Andrea M Cooper
Journal:  Cytokine       Date:  2008-01-22       Impact factor: 3.861

Review 9.  Why does tuberculosis lead to specific inflammation?

Authors:  Isamu Sugawara
Journal:  Nihon Hansenbyo Gakkai Zasshi       Date:  2009-09

10.  A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock.

Authors:  Y Chvatchko; A J Hoogewerf; A Meyer; S Alouani; P Juillard; R Buser; F Conquet; A E Proudfoot; T N Wells; C A Power
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

View more
  8 in total

1.  OX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis infection.

Authors:  Robert J Snelgrove; Megan M Cornere; Lorna Edwards; Belinda Dagg; James Keeble; Angela Rodgers; Daphne E Lyonga; Graham R Stewart; Douglas B Young; Barry Walker; Tracy Hussell
Journal:  J Infect Dis       Date:  2012-02-07       Impact factor: 5.226

2.  CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function.

Authors:  Eileen A Forde; Rukiye-Nazan E Dogan; William J Karpus
Journal:  J Neuroimmunol       Date:  2011-05-14       Impact factor: 3.478

Review 3.  γδ T cell migration: Separating trafficking from surveillance behaviors at barrier surfaces.

Authors:  Matthew A Fischer; Natasha B Golovchenko; Karen L Edelblum
Journal:  Immunol Rev       Date:  2020-08-26       Impact factor: 12.988

4.  Role of CC chemokine receptor 4 in natural killer cell activation during acute cigarette smoke exposure.

Authors:  Valerie R Stolberg; Brian Martin; Peter Mancuso; Michal A Olszewski; Christine M Freeman; Jeffrey L Curtis; Stephen W Chensue
Journal:  Am J Pathol       Date:  2013-12-09       Impact factor: 4.307

5.  Lung transplantation affects expression of the chemokine receptor type 4 on specific T cell subsets.

Authors:  A W M Paantjens; E A van de Graaf; J M Kwakkel-van Erp; T Hoefnagel; D A van Kessel; J M M van den Bosch; H G Otten
Journal:  Clin Exp Immunol       Date:  2011-10       Impact factor: 4.330

Review 6.  Chemokines shape the immune responses to tuberculosis.

Authors:  Samantha R Slight; Shabaana A Khader
Journal:  Cytokine Growth Factor Rev       Date:  2012-11-16       Impact factor: 7.638

7.  Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4.

Authors:  Zamaneh Mikhak; James P Strassner; Andrew D Luster
Journal:  J Exp Med       Date:  2013-08-19       Impact factor: 14.307

8.  Design and synthesis of a series of pyrido[2,3-d]pyrimidine derivatives as CCR4 antagonists.

Authors:  Hongwei Gong; Hui Qi; Wei Sun; Yang Zhang; Dan Jiang; Junhai Xiao; Xiaohong Yang; Ying Wang; Song Li
Journal:  Molecules       Date:  2012-08-20       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.